WILMINGTON — Merck & Company revealed that its $1 billion research and development lab at the Chestnut Run Innovation & Science Park (CRISP) will not only be the main production plant for Keytruda in the United States, but also the focal point for the next wave of its drug discovery.
The complex, named Merck Wilmington Biotech, will include three buildings with a collective 470,000…
…
Continue reading this article at;
https://delawarebusinesstimes.com/news/merck-keytruda-in-wilmington/
delawarebusinesstimes.com
Feed Name : Delaware Business Times
Bioscience & Pharmaceutical,Commercial Real Estate,Economic Development,New Castle County,News
hashtags : #Merck #onshore #cancer #drug #Keytruda #Wilmington